PT Millennium Pharmacon International Tbk
Jakarta Stock Exchange SDPC.JK
PT Millennium Pharmacon International Tbk Price to Earnings Ratio (P/E) on January 14, 2025: 4.79
-
PT Millennium Pharmacon International Tbk 52-week high Price to Earnings Ratio (P/E) is 6.46 on November 22, 2024, which is 34.72% above the current Price to Earnings Ratio (P/E).
-
PT Millennium Pharmacon International Tbk 52-week low Price to Earnings Ratio (P/E) is 4.52 on June 27, 2024, which is -5.75% below the current Price to Earnings Ratio (P/E).
-
PT Millennium Pharmacon International Tbk average Price to Earnings Ratio (P/E) for the last 52 weeks is 5.21.
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
| CEO | Mr. Ahmad Bin Abu Bakar |
| IPO Date | Sept. 3, 2001 |
| Location | Indonesia |
| Headquarters | Crown Bungur Arteri |
| Employees | 1,172 |
| Sector | Health Care |
| Industries | |
PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines, dietary supplements, and medical devices in Indonesia. The company distributes its products through drug stores, pharmacies, hospitals, supermarkets, and retail shops. As of December 31, 2021, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
Past 5 years
USD 0.05
USD 0.01
USD 0.38
USD 0.01
StockViz Staff
January 15, 2025
Any question? Send us an email